Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Non-Current Assets (2016 - 2025)

Anaptysbio (ANAB) has disclosed Other Non-Current Assets for 10 consecutive years, with $256000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $256000.0, compared with a TTM value of $256000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $256000.0, changed 0.0% over the prior year.
  • Other Non-Current Assets was $256000.0 for Q4 2025 at Anaptysbio, roughly flat from $256000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $258000.0 in Q2 2021 and bottomed at $256000.0 in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $256111.1, with a median of $256000.0 recorded in 2021.
  • Peak annual rise in Other Non-Current Assets hit 326.67% in 2021, while the deepest fall reached 80.95% in 2021.
  • Year by year, Other Non-Current Assets stood at $256000.0 in 2021, then changed by 0.0% to $256000.0 in 2022, then changed by 0.0% to $256000.0 in 2023, then changed by 0.0% to $256000.0 in 2024, then changed by 0.0% to $256000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for ANAB at $256000.0 in Q4 2025, $256000.0 in Q3 2025, and $256000.0 in Q2 2025.